Tex. Gov't Code § 549.0352 · Subchapter H. MEDICAID DRUG UTILIZATION REVIEW PROGRAM
DRUG USE REVIEWS.
Text — Current through the 89th 2nd Called Legislative Session, 2025
(a) The commission shall provide for an increase in the number and types of retrospective drug use reviews performed each year under the Medicaid Drug Utilization Review Program in comparison to the number and types of reviews performed in the state fiscal year ending August 31, 2009.
(b) In determining the number and types of drug use reviews to be performed, the commission shall:
(1) allow for the repeat of retrospective drug use reviews that address ongoing drug therapy problems and that, in previous years, improved client outcomes and reduced Medicaid spending;
(2) consider implementing disease-specific retrospective drug use reviews that:
(A) address ongoing drug therapy problems in this state; and
(B) reduced Medicaid prescription drug use expenditures in another state; and
(3) regularly examine Medicaid prescription drug claims data to identify occurrences of potential drug therapy problems that may be addressed by repeating successful retrospective drug use reviews performed in this state or another state.
Notes and commentary — not statutory text
History
Added by Acts 2023, 88th Leg., R.S., Ch. 769 (H.B. 4611), Sec. 1.01, eff. April 1, 2025.
Source of truth
- Edition
- Current through the 89th 2nd Called Legislative Session, 2025
- Official file
- https://statutes.capitol.texas.gov/Docs/GV/htm/GV.549.htm
- Text hash
- sha256 6264455f4058eb131af4ff540533d8f888ae9471834e437d026285e70ee46879
- Composed by
- compose_tx.py 2026-10-05: the Legislative Council's chapter files read in document order; verify_tx.py's independent reading (lxml DOM walk) agrees character for character
Procedural information only. Not legal advice and not a substitute for the advice of an attorney. Confirm the current text with the official publisher before relying on it.